Loading clinical trials...
Loading clinical trials...
A study of pregabalin efficacy and safety in a racially and culturally diverse group of subjects with painful diabetic peripheral neuropathy (DPN).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT05670600 · Diabetic Neuropathy, Painful
NCT04055090 · Painful Diabetic Neuropathy, Diabetic Neuropathy, Painful
NCT05917249 · Diabetic Neuropathy, Painful
NCT06152887 · Diabetic Neuropathy, Painful, Diabetes Mellitus, Type 1
NCT04988321 · Diabetic Neuropathy, Painful
Pfizer Investigational Site
Buenos Aires
Pfizer Investigational Site
Belo Horizonte, Minas Gerais
Pfizer Investigational Site
Niterói, Rio de Janeiro
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions